4O21 Stock Overview
CO2 Gro Inc., together with its subsidiaries, focuses on commercializing patent-licensed CO2 gas infusion technology and patent-pending US PTO CO2 delivery solutions system.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
CO2 Gro Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.022 |
| 52 Week High | CA$0.086 |
| 52 Week Low | CA$0.012 |
| Beta | 1.46 |
| 1 Month Change | 46.67% |
| 3 Month Change | -43.59% |
| 1 Year Change | -70.67% |
| 3 Year Change | -89.00% |
| 5 Year Change | -94.01% |
| Change since IPO | -72.15% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4O21 | DE Machinery | DE Market | |
|---|---|---|---|
| 7D | -17.0% | -2.6% | -2.5% |
| 1Y | -70.7% | 21.8% | -0.4% |
Return vs Industry: 4O21 underperformed the German Machinery industry which returned 21.8% over the past year.
Return vs Market: 4O21 underperformed the German Market which returned -0.4% over the past year.
Price Volatility
| 4O21 volatility | |
|---|---|
| 4O21 Average Weekly Movement | 74.2% |
| Machinery Industry Average Movement | 3.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 4O21's share price has been volatile over the past 3 months.
Volatility Over Time: 4O21's weekly volatility has increased from 46% to 74% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | John Archibald | www.co2gro.ca |
CO2 Gro Inc., together with its subsidiaries, focuses on commercializing patent-licensed CO2 gas infusion technology and patent-pending US PTO CO2 delivery solutions system. The company operates in the United states and Canada. CO2 Gro Inc. was incorporated in 2010 and is headquartered in Toronto, Canada.
CO2 Gro Inc. Fundamentals Summary
| 4O21 fundamental statistics | |
|---|---|
| Market cap | €3.32m |
| Earnings (TTM) | -€931.00k |
| Revenue (TTM) | €274.84k |
9.7x
P/S Ratio-2.9x
P/E RatioIs 4O21 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4O21 income statement (TTM) | |
|---|---|
| Revenue | CA$402.76k |
| Cost of Revenue | CA$251.96k |
| Gross Profit | CA$150.80k |
| Other Expenses | CA$1.52m |
| Earnings | -CA$1.36m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.014 |
| Gross Margin | 37.44% |
| Net Profit Margin | -338.75% |
| Debt/Equity Ratio | 95.4% |
How did 4O21 perform over the long term?
See historical performance and comparison